The memantine market overview involves neuroprotective properties of memantine for treatment of moderate to severe forms of Alzheimer's disease. Memantine is an NMDA receptor antagonist approved as an add-on therapy to cholinesterase inhibitors for patients with moderate to severe Alzheimer's disease. It regulates glutamate activity to inhibit neurotoxicity and protect neurons from...
Romaian 
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Portuguese (Brazil)
Greek
urdu